Cargando…
Oncological and urinary outcomes following low‐dose‐rate brachytherapy with a median follow‐up of 11.8 years
OBJECTIVES: To examine the long‐term oncological outcomes and urological morbidity of low‐dose‐rate prostate brachytherapy (LDRBT) monotherapy using live intraoperative dosimetry planning and an automated needle navigation delivery system for the treatment of men with low and intermediate‐risk prost...
Autores principales: | Yaxley, William John, Mackean, James, Desai, Devang J., Tsang, Gail, Dixon, Judi, Samaratunga, Hemamali, Delahunt, Brett, Egevad, Lars, Gardiner, Robert A., Yaxley, John William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804913/ https://www.ncbi.nlm.nih.gov/pubmed/35791775 http://dx.doi.org/10.1111/bju.15845 |
Ejemplares similares
-
The current status of renal cell carcinoma and prostate carcinoma grading
por: Delahunt, Brett, et al.
Publicado: (2018) -
Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin
por: Lindh, Claes, et al.
Publicado: (2022) -
Prostate cancer survivorship care: if not now, when?
por: Dunn, Jeffrey, et al.
Publicado: (2021) -
Pathological predictors of (18)F‐DCFPyL prostate‐specific membrane antigen‐positive recurrence after radical prostatectomy
por: Perry, Elisa, et al.
Publicado: (2022) -
The safety of surgical mesh: what is online video content teaching our patients?
por: Parkin, Cameron James, et al.
Publicado: (2022)